24 Feb Burrill to lead $1B biotech fund
The Minneapolis Star Tribune is reporting that the developer of a planned 1.7 million-square-foot biosciences park in southeast Minnesota is close to snagging a deal that will create a billion-dollar venture fund to attract start-up biotech companies to the state. Steven Burrill (photo), a well known venture capitalist, will reportedly be the lead investor. California-based Tower Investments is expected to provide $100 million of that. The Star Tribune quotes sources close to the deal.
The fund will use the money to attract 30 biotech companies to the Elk Run facility in the state, according to the report. The Mayo Clinic in Rochester will collaborate on the project, steering its spin-offs to the park.
Read full article